Why the study?
Despite exponential worldwide growth, MitraClip adoption in Asia has been more gradual, and very few publications describe its use in Asian populations.
This review highlights the gradual adoption, clinical experience, and challenges of using the MitraClip device for percutaneous edge-to-edge mitral valve repair in Asian populations.
Answers are grounded in this paper and cite their sources.
Reinforces MitraClip role in functional MR; extends Western RCT evidence to broader global adoption.
In the United States and Europe, percutaneous edge-to-edge repair of the mitral valve with the MitraClip device for patients with severe degenerative mitral regurgitation who are at prohibitive surgical risk has been well-established. Recent randomized controlled trials have also demonstrated significant clinical benefits with the use of the device in selected patients with functional mitral regurgitation. Thus far, >80,000 patients in more than 50 countries have undergone the MitraClip procedure. Despite the exponential growth worldwide, the rate of MitraClip adoption in Asia has been more gradual. In addition, very few publications describe the use of MitraClip in Asian populations. This review aims to describe the Asian experience with the MitraClip device and the challenges faced.
No takes yet. Share an insight, caveat, or question.
Wong et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: